Cerus Net Profit Margin 2010-2025 | CERS
Cerus net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Cerus Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-03-31 | $0.21B | $-0.02B | -9.62% |
| 2024-12-31 | $0.20B | $-0.02B | -10.89% |
| 2024-09-30 | $0.20B | $-0.02B | -10.10% |
| 2024-06-30 | $0.19B | $-0.02B | -12.37% |
| 2024-03-31 | $0.19B | $-0.03B | -16.23% |
| 2023-12-31 | $0.19B | $-0.04B | -19.89% |
| 2023-09-30 | $0.18B | $-0.05B | -27.17% |
| 2023-06-30 | $0.18B | $-0.05B | -27.87% |
| 2023-03-31 | $0.18B | $-0.05B | -25.14% |
| 2022-12-31 | $0.19B | $-0.04B | -22.34% |
| 2022-09-30 | $0.19B | $-0.04B | -19.79% |
| 2022-06-30 | $0.18B | $-0.04B | -22.40% |
| 2022-03-31 | $0.17B | $-0.05B | -27.75% |
| 2021-12-31 | $0.16B | $-0.05B | -33.13% |
| 2021-09-30 | $0.14B | $-0.06B | -40.28% |
| 2021-06-30 | $0.13B | $-0.06B | -45.80% |
| 2021-03-31 | $0.12B | $-0.06B | -50.00% |
| 2020-12-31 | $0.12B | $-0.06B | -51.30% |
| 2020-09-30 | $0.11B | $-0.06B | -57.94% |
| 2020-06-30 | $0.10B | $-0.07B | -65.35% |
| 2020-03-31 | $0.10B | $-0.07B | -71.88% |
| 2019-12-31 | $0.09B | $-0.07B | -77.42% |
| 2019-09-30 | $0.09B | $-0.07B | -81.61% |
| 2019-06-30 | $0.08B | $-0.07B | -80.72% |
| 2019-03-31 | $0.08B | $-0.06B | -77.50% |
| 2018-12-31 | $0.08B | $-0.06B | -76.00% |
| 2018-09-30 | $0.07B | $-0.05B | -70.27% |
| 2018-06-30 | $0.07B | $-0.05B | -75.00% |
| 2018-03-31 | $0.06B | $-0.06B | -91.67% |
| 2017-12-31 | $0.05B | $-0.06B | -117.65% |
| 2017-09-30 | $0.04B | $-0.06B | -143.18% |
| 2017-06-30 | $0.04B | $-0.06B | -156.10% |
| 2017-03-31 | $0.04B | $-0.07B | -166.67% |
| 2016-12-31 | $0.04B | $-0.06B | -161.54% |
| 2016-09-30 | $0.04B | $-0.06B | -172.97% |
| 2016-06-30 | $0.04B | $-0.07B | -188.57% |
| 2016-03-31 | $0.04B | $-0.06B | -182.86% |
| 2015-12-31 | $0.04B | $-0.06B | -160.00% |
| 2015-09-30 | $0.04B | $-0.06B | -174.29% |
| 2015-06-30 | $0.04B | $-0.06B | -151.35% |
| 2015-03-31 | $0.04B | $-0.05B | -129.73% |
| 2014-12-31 | $0.04B | $-0.04B | -105.41% |
| 2014-09-30 | $0.04B | $-0.03B | -69.44% |
| 2014-06-30 | $0.04B | $-0.04B | -94.59% |
| 2014-03-31 | $0.04B | $-0.03B | -89.47% |
| 2013-12-31 | $0.04B | $-0.04B | -110.00% |
| 2013-09-30 | $0.04B | $-0.04B | -95.24% |
| 2013-06-30 | $0.04B | $-0.02B | -56.41% |
| 2013-03-31 | $0.04B | $-0.02B | -44.74% |
| 2012-12-31 | $0.04B | $-0.02B | -43.24% |
| 2012-09-30 | $0.04B | $-0.02B | -61.11% |
| 2012-06-30 | $0.04B | $-0.02B | -45.95% |
| 2012-03-31 | $0.04B | $-0.02B | -60.00% |
| 2011-12-31 | $0.03B | $-0.02B | -51.52% |
| 2011-09-30 | $0.03B | $-0.01B | -37.93% |
| 2011-06-30 | $0.03B | $-0.02B | -68.00% |
| 2011-03-31 | $0.02B | $-0.02B | -70.83% |
| 2010-12-31 | $0.02B | $-0.02B | -73.91% |
| 2010-09-30 | $0.02B | $-0.02B | -90.91% |
| 2010-06-30 | $0.02B | $-0.02B | -100.00% |
| 2010-03-31 | $0.02B | $-0.02B | -110.00% |
| 2009-12-31 | $0.02B | $-0.02B | -141.18% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.235B | $0.180B |
| Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.137B | 27.79 |
| Boston Scientific (BSX) | United States | $154.602B | 38.70 |
| Stryker (SYK) | United States | $145.939B | 30.51 |
| EssilorLuxottica (ESLOY) | France | $128.884B | 0.00 |
| Medtronic (MDT) | Ireland | $105.694B | 14.98 |
| Haleon (HLN) | United Kingdom | $51.038B | 29.05 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.182B | 0.00 |
| ResMed (RMD) | United States | $35.941B | 27.00 |
| GE HealthCare Technologies (GEHC) | United States | $32.753B | 15.55 |
| Agilent Technologies (A) | United States | $32.296B | 20.98 |
| Terumo (TRUMY) | Japan | $27.790B | 36.10 |
| Insulet (PODD) | United States | $22.791B | 89.46 |
| Koninklijke Philips (PHG) | Netherlands | $21.581B | 15.51 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.467B | 11.86 |
| Baxter (BAX) | United States | $15.754B | 11.76 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.622B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.194B | 21.55 |
| Lantheus Holdings (LNTH) | United States | $5.225B | 13.18 |
| Prestige Consumer Healthcare (PBH) | United States | $4.175B | 18.65 |
| Perrigo (PRGO) | Ireland | $3.730B | 9.45 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.309B | 24.40 |
| Haemonetics (HAE) | United States | $3.259B | 14.85 |
| Envista Holdings (NVST) | United States | $3.129B | 26.00 |
| GN Store Nord (GNNDY) | Denmark | $2.215B | 18.35 |
| QuidelOrtho (QDEL) | United States | $2.080B | 14.30 |
| LeMaitre Vascular (LMAT) | United States | $1.832B | 40.94 |
| AtriCure (ATRC) | United States | $1.687B | 0.00 |
| Neogen (NEOG) | United States | $1.348B | 17.25 |
| Acuren (TIC) | United States | $1.300B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.212B | 12.30 |
| Kestra Medical Technologies (KMTS) | United States | $1.165B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
| BioLife Solutions (BLFS) | United States | $1.060B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.000B | 12.78 |
| InMode (INMD) | Israel | $0.922B | 9.29 |
| CeriBell (CBLL) | United States | $0.615B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.604B | 0.00 |
| Evolus (EOLS) | United States | $0.602B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.582B | 0.00 |
| Valneva SE (VALN) | France | $0.535B | 0.00 |
| Owens & Minor (OMI) | United States | $0.502B | 4.17 |
| Tilray Brands (TLRY) | Canada | $0.468B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.461B | 0.00 |
| Surmodics (SRDX) | United States | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.342B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.333B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.94 |
| Canopy Growth (CGC) | Canada | $0.314B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.310B | 55.20 |
| Sanara MedTech (SMTI) | United States | $0.261B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.260B | 21.90 |
| ZimVie (ZIMV) | United States | $0.250B | 11.35 |
| Sanuwave Health (SNWV) | United States | $0.241B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.237B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.207B | 0.00 |
| Quanterix (QTRX) | United States | $0.203B | 0.00 |
| Brainsway (BWAY) | Israel | $0.197B | 52.15 |
| Biote (BTMD) | United States | $0.197B | 5.53 |
| Omeros (OMER) | United States | $0.195B | 0.00 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.177B | 14.44 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.142B | 17.46 |
| Jin Medical (ZJYL) | China | $0.119B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.089B | 11.52 |
| MacroGenics (MGNX) | United States | $0.088B | 0.00 |
| Agape ATP (ATPC) | $0.088B | 0.00 | |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| Apyx Medical (APYX) | United States | $0.060B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| United Health Products (UEEC) | United States | $0.054B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.048B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.19 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Nephros (NEPH) | United States | $0.028B | 37.57 |
| Safety Shot (SHOT) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |